insights_auto
Nega ONCY oshdi 2,31%?
Batafsil oʻrganishchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
0,56 US$
arrow_upward
+2,31%(+0,013) 1K
0,55 US$
arrow_downward
-1,26% (-0,0070)bedtimeYopilgandan keyin
Savdolar yopilgan: 9-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoONCY tikeri uchun statistika yaratilmoqda...
Ochish
0,55 US$
Yuqori
0,57 US$
Past
0,52 US$
Bozor kapitali
73,63 mln
Oʻrtacha hajm
1,05 mln
Hajmi
1,46 mln
52 haftalik eng yuqori
1,32 US$
52 haftalik eng past
0,52 US$
Beta
1,15
Muomaladagi aksiyalar
127,51 mln
Xodimlar soni
29
Ochish
0,55 US$
Yuqori
0,57 US$
Past
0,52 US$
Bozor kapitali
73,63 mln
Oʻrtacha hajm
1,05 mln
Hajmi
1,46 mln
52 haftalik eng yuqori
1,32 US$
52 haftalik eng past
0,52 US$
Beta
1,15
Muomaladagi aksiyalar
127,51 mln
Xodimlar soni
29
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
MarketBeat
·
40 daqiqa oldin
Intel Corporation (NASDAQ:INTC) Stock Has Average Target Price of $109.06
Yahoo Finance
·
1 soat oldin
Should Twilio’s (TWLO) Inclusion in the S&P 500 Require Action From Existing Investors?
Mitrade
·
1 soat oldin
S&P 500 Near Record Highs: Can the Rally Continue? (October 2026 Outlook)
Seeking Alpha
·
2 soat oldin
Regression To Trend: S&P Composite 214% Above Trend In September
Profil
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Oncolytics Biotech Inc haqida
CEO-
Xodimlar soni29
Asos solingan1998
Bosh ofislarKalgari, Alberta, Kanada
Sektor-
Veb-saytoncolyticsbiotech.com